The IGG contributed to sessions by selecting speakers on topics relevant to the industrial community. These included:
James Whitwell, Covance, Harrogate: Extended treatment with recovery is required for detection of certain chemicals in the human peripheral blood lymphocyte assay.
Amy Wilson, AstraZeneca, Cambridge: High content comparison of GeneTox responses in parent and p53 knock out cell lines.
Shareen Doak, Swansea University: 3D liver spheroids for genotoxicity testing.
There were also a number of industry-relevant posters and talks in the NUKEMS session from Industrial-sponsored students including:
NUKEMS talks:
Sarah Gee, AstraZeneca, Cambridge: Evaluation of 3D bone marrow
models for genotoxicity testing
Lauren Clarke, University of Bath/AstraZeneca Cambridge: Utilising amplicon sequencing and qPCR to further understand the EMS response in the in vitro Pig-a assay in L5178Y
Posters:
Rebakah Beck, Univeristy of Manchester/AstraZeneca Cambridge: Generation of epigenetic fingerprints following compound exposure.
Alex Vernon, University of the West of England/AstraZeneca Cambridge: Evaluating different 3D scaffolds for the development of an in vitro bone marrow model for genotoxicity testing.
Melvyn Lloyd, Covance, Harrogate: Genotoxicity evaluation of tobacco and nicotine delivery products
Grace Kocks and Richard Williams, Lhasa, Leeds: How low can you go? An analysis of lowest effective dose in the Ames test
Awards
There were awards for industrial-sponsored students including:
Best Poster and Best Lightning Presentation: Rebekah Beck, AstraZeneca, University of Manchester
Best Poster: Felix Dobbs, AstraZeneca, Cardiff University
Best Overall Presentation: Lauren Clarke, AstraZeneca/University of Bath
Our very own committee member, Rhiannon David, was awarded the UKEMS Young Scientist Award and gave an award lecture at the meeting.
Congratulations all!
UKEMS 2019
UKEMS 2019 will be held in Robinson College, Cambridge, from 15th – 17th April. See IGG at UKEMS 2019 for more information or follow us on Twitter or LinkedIn.